Provided by Tiger Fintech (Singapore) Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.12
+0.01000.24%
Post-market: 4.10-0.0200-0.49%16:48 EDT
Volume:692.59K
Turnover:2.85M
Market Cap:345.11M
PE:-2.91
High:4.13
Open:4.10
Low:4.10
Close:4.11
Loading ...

Sector Update: Health Care Stocks Flat to Lower Premarket Monday

MT Newswires Live
·
10 Mar

Recession Fears Drive Premarket Losses for US Equity

MT Newswires Live
·
10 Mar

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Trade Uncertainty Stokes Inflation Fears

MT Newswires Live
·
10 Mar

Top Premarket Gainers

MT Newswires Live
·
10 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Airbnb, Beacon, Redfin

Reuters
·
10 Mar

US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory

Benzinga
·
10 Mar

BUZZ-Checkpoint Therapeutics rises on $355 million Sun Pharma buyout deal

Reuters
·
10 Mar

Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma

Dow Jones
·
10 Mar

Deals of the day-Mergers and acquisitions

Reuters
·
10 Mar

Checkpoint Therapeutics Jumps 66% Premarket After Sun Pharma to Acquire Co for $355 Mln

THOMSON REUTERS
·
10 Mar

Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical

MT Newswires Live
·
10 Mar

India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln

Investing.com
·
10 Mar

INDIA STOCKS-Indian stocks set for muted start after last week's gains

Reuters
·
10 Mar

India's Sun Pharma to acquire Checkpoint Therapeutics

Reuters
·
10 Mar

Checkpoint Therapeutics Inc - Stockholders Will Also Receive a Contingent Value Right for up to $0.70 per Share on Achievement of a Milestone

THOMSON REUTERS
·
10 Mar

Checkpoint Therapeutics Inc - Upfront Cash Payment of $4.10 per Share of Common Stock,Representing Aggregate Upfront Consideration of up to $355 Mln

THOMSON REUTERS
·
10 Mar

Sun Pharma to Acquire Checkpoint Therapeutics

PR Newswire
·
10 Mar

Sun Pharma - Co to Acquire Checkpoint Therapeutics for Upto $355 Million

THOMSON REUTERS
·
10 Mar

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) stock most popular amongst individual investors who own 56%, while public companies hold 14%

Simply Wall St.
·
03 Feb

Checkpoint Therapeutics Initiated at Buy by D. Boral Capital

Dow Jones
·
13 Jan